A re-appraisal of volume status and renal function impairmentin chronic heart failure: Combined effects of pre-renal failure and venous congestion on renal function

Heart Failure Reviews

Volumn 17, Issue 2, 2012, Pages 263-270

  Sinkeler, Steef J ^a   Damman, Kevin ^a   Van Veldhuisen, Dirk J ^a   Hillege, Hans ^a   Navis, Gerjan ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Chronic heart failure; Dietary sodium; Renal function; Renal hemodynamics; Salt; Volume status

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; LOSARTAN; PLACEBO;

ADD ON THERAPY; ARTICLE; ATHEROSCLEROSIS; BLOOD VOLUME; CARDIAC PATIENT; DISEASE ASSOCIATION; DRUG TARGETING; FORWARD HEART FAILURE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART LEFT VENTRICLE FILLING PRESSURE; HEART OUTPUT; HEART VENTRICLE FILLING; HEMODYNAMICS; HUMAN; HYPERVOLEMIA; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY FUNCTION; NONHUMAN; PATHOPHYSIOLOGY; SODIUM RETENTION; VENOUS CONGESTION;

CHRONIC DISEASE; HEART FAILURE; HEMODYNAMICS; HOMEOSTASIS; HUMANS; HYPEREMIA; KIDNEY; RENAL INSUFFICIENCY;

EID: 84862517476     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-011-9233-7     Document Type: Article

References (41)

1. Smilde TD, Hillege HL, Voors AA et al (2004) Prognostic importance of renal function in patients with early heart failure and mild left ventricular dysfunction. Am J Cardiol 94: 240-243
2. Smilde TD, Hillege HL, Navis G et al (2006) Difference in longterm prognostic value of renal function between ischemic and non-ischemic mild heart failure. Int J Cardiol 107: 73-77
3. Leithe ME, Margorien RD, Hermiller JB et al (1984) Relationship between central hemodynamics and regional blood flow in normal subjects and in patients with congestive heart failure. Circulation 69: 57-64
4. Ljungman S, Laragh JH, Cody RJ (1990) Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function. Drugs 39(Suppl 4): 10-21
5. Smilde TD, Damman K, van der Harst P et al (2009) Differential associations between renal function and "modifiable" risk factors in patients with chronic heart failure. Clin Res Cardiol 98: 121-129
6. Nohria A, Hasselblad V, Stebbins A et al (2008) Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol 51: 1268-1274
7. Weinfeld MS, Chertow GM, Stevenson LW (1999) Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure. Am Heart J 138: 285-290
8. Mullens W, Abrahams Z, Skouri HN et al (2008) Elevated intraabdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function? J Am Coll Cardiol 51: 300-306
9. Mullens W, Abrahams Z, Francis GS et al (2009) Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53: 589-596
10. Sullivan MJ, Cobb FR (1992) Central hemodynamic response to exercise in patients with chronic heart failure. Chest 101: 340S- 346S
11. Ito S, Ren Y (1993) Evidence for the role of nitric oxide in macula densa control of glomerular hemodynamics. J Clin Invest 92: 1093-1098
12. Winton FR (1931) The influence of venous pressure on the isolated mammalian kidney. J Physiol 72: 49-61
13. Blake W, Wegria R, Keating RP, Ward HP (1949) Effect of increased renal venous pressure on renal function. Am J Physiol 157: 1-13
14. Bradley S, Bradley G (1947) The effect of increased intraabdominal pressure on renal function in man. J Clin Invest 26: 1010-1022
15. Damman K, van Deursen VM, Navis G et al (2009) Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 53: 582-588
16. Damman K, Voors AA, Hillege HL et al (2010) Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality. Eur J Heart Fail 12: 974-982
17. Damman K, Navis G, Smilde TD et al (2007) Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail 9: 872-878
18. Burnett JC Jr, Knox FG (1980) Renal interstitial pressure and sodium excretion during renal vein constriction. Am J Physiol 238: F279-F282
19. Colombo PC, Rastogi S, Onat D et al (2009) Activation of endothelial cells in conduit veins of dogs with heart failure and veins of normal dogs after vascular stretch by acute volume loading. J Card Fail 15: 457-463
20. DiPetrillo K, Coutermarsh B, Gesek FA (2003) Urinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes. Am J Physiol Renal Physiol 284: F113-F121
21. Hasegawa G, Nakano K, Sawada M et al (1991) Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy. Kidney Int 40: 1007-1012
22. Colombo PC, Banchs JE, Celaj S et al (2005) Endothelial cell activation in patients with decompensated heart failure. Circulation 111: 58-62
23. Dickstein K, Cohen-Solal A, Filippatos G et al (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European society of cardiology. Developed in collaboration with the heart failure association of the ESC (HFA) and endorsed by the European society of intensive care medicine (ESICM). Eur Heart J 29: 2388-2442
24. Wilcox CS, Mitch WE, Kelly RA et al (1983) Response of the kidney to furosemide. I. Effects of salt intake and renal compensation. J Lab Clin Med 102: 450-458
25. van Zuilen AD, Blankestijn PJ, van Buren M et al (2010) Quality of care in patients with chronic kidney disease is determined by hospital specific factors. Nephrol Dial Transplant 25: 3647-3654
26. Cianciaruso B, Capuano A, D'Amaro E et al (1989) Dietary compliance to a low protein and phosphate diet in patients with chronic renal failure. Kidney Int Suppl 27: S173-S176
27. Krikken JA, Laverman GD, Navis G (2009) Benefits of dietary sodium restriction in the management of chronic kidney disease. Curr Opin Nephrol Hypertens 18: 531-538
28. sHeart Failure Society Of America (2006) Heart failure in patients with left ventricular systolic dysfunction. J Card Fail 12: e38-e57
29. Gottlieb SS, Brater DC, Thomas I et al (2002) BG9719 (CVT- 124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation 105: 1348-1353
30. Francis GS, Benedict C, Johnstone DE et al (1990) Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 82: 1724-1729
31. Brilla CG, Matsubara LS, Weber KT (1993) Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. J Mol Cell Cardiol 25: 563-575
32. Zhu A, Yoneda T, Demura M et al (2009) Effect of mineralocorticoid receptor blockade on the renal renin-angiotensin system in Dahl salt-sensitive hypertensive rats. J Hypertens 27: 800-805
33. Ito H, Nagatomo Y, Kohno T et al (2010) Differential effects of carvedilol and metoprolol on renal function in patients with heart failure. Circ J 74: 1578-1583
34. Slagman MC, Navis G, Laverman GD (2010) Reversible effects of diuretics added to renin-angiotensin-aldosterone system blockade: impact on interpretation of long-term kidney function outcome. Am J Kidney Dis 56: 601-602
35. Testani JM, Chen J, McCauley BD et al (2010) Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation 122: 265-272
36. Felker GM, O'Connor CM (2010) American College of Cardiology Annual Scientific Sessions; Atlanta, GA. Ref Type: Conference Proceeding
37. Aronson D, Mittleman MA, Burger AJ (2004) Elevated blood urea nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure. Am J Med 116: 466-473
38. Vogt L, Waanders F, Boomsma F et al (2008) Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan. J Am Soc Nephrol 19: 999-1007
39. Heeg JE, de Jong PE, van der Hem GK, de Zeeuw D (1989) Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. Kidney Int 36: 272-279
40. Cook NR, Cutler JA, Obarzanek E et al (2007) Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ 334: 885-888
41. Slagman MC, Sinkeler SJ, Hemmelder MH et al (2010) Erythropoietin is reduced by combination of diuretic therapy and RAAS blockade in proteinuric renal patients with preserved renal function. Nephrol Dial Transplant 25: 3256-3260